世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

牛ヘパリンナトリウムの世界市場調査レポート2023年版


Global Bovine Heparin Sodium Market Research Report 2023

世界の牛ヘパリンナトリウム市場は、2022年に4020万米ドルと評価され、2029年には5740万米ドルに達すると予測され、予測期間2023-2029年に5.80%のCAGRを目撃しています。COVID-19とロシア・ウクライナ戦争の影響... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2023年5月19日 US$2,900
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

世界の牛ヘパリンナトリウム市場は、2022年に4020万米ドルと評価され、2029年には5740万米ドルに達すると予測され、予測期間2023-2029年に5.80%のCAGRを目撃しています。COVID-19とロシア・ウクライナ戦争の影響は、市場規模を推定する際に考慮した。
牛ヘパリンナトリウムの世界の主要メーカーは、Kin Master Produtos Químicos Ltda、Syntex、Bacto Chem、Wegmed - Caminhos Medicinais Ltda、など。2022年には、世界のトップ3ベンダーが売上の約70.89%を占めています。

レポートのスコープ
本レポートは、牛ヘパリンナトリウムの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場の競争状況を把握し、現在の市場における自社のポジションを分析し、牛ヘパリンナトリウムに関するビジネス上の意思決定を行うことを目的としています。

牛ヘパリンナトリウムの市場規模、推計、予測は、2022年を基準年とみなし、2018年から2029年までの期間の履歴と予測データを、生産量/出荷量(Kg)および収益($ million)で提供します。本レポートは、世界の牛ヘパリンナトリウム市場を包括的に区分しています。タイプ別、用途別、プレイヤー別の製品に関する地域別市場規模も掲載しています。
市場をより深く理解するために、競争環境、主要な競合他社、それぞれの市場ランクのプロフィールを掲載しています。また、技術動向や新製品開発についても解説しています。
本レポートは、牛ヘパリンナトリウムのメーカー、新規参入企業、本市場の産業チェーン関連企業にとって、市場全体と企業別、タイプ別、用途別、地域別のサブセグメントにおける収益、生産、平均価格に関する情報を提供します。

会社別
Kin Master Produtos Químicos Ltda(キンマスター プロデュートス キミコス リミターダ
シンテックス
バクト・ケム
ウェグメッド-カミンホスメディシナイズリミターダ
アライアンス・ブラジル
ラリントン製薬
河北長山生物化学製薬株式会社
蘇州ロンシファーマ

用途別セグメント
静脈血栓塞栓症治療薬
心房細動・粗動の除細動療法
妊娠の合併症
その他

地域別生産量
南米
インド
中国

地域別消費量
北アメリカ
米国
カナダ
メキシコ

アジア・パシフィック
中国
日本
韓国
東南アジア
インド
オーストラリア

欧州
ドイツ
フランス
英国
イタリア
スペイン
その他のヨーロッパ

南米
アルゼンチン
南米のその他

中近東・アフリカ
中近東
アフリカ

コアチャプター
第1章:報告書の範囲、異なる市場セグメント(地域別、タイプ別、用途別など)のエグゼクティブサマリー、各市場セグメントの市場規模、将来の開発可能性などを紹介します。市場の現状と、短中期および長期の進化が見込まれる市場について、ハイレベルな視点を提供します。
第2章:牛ヘパリンナトリウムメーカーの競争環境、価格、生産量、金額シェア、最新の開発計画、M&A情報などを詳細に分析。
第3章:牛ヘパリンナトリウムの地域/国別の生産/生産量、価値。今後6年間の各地域の市場規模や発展の可能性を定量的に分析しています。
第4章 牛ヘパリンナトリウムの地域レベルおよび国レベルでの消費量。各地域とその主要国の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、将来の発展見通し、市場空間、生産量などを紹介する。
第5章:タイプ別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模や発展可能性を網羅し、読者が異なる市場セグメントにおけるブルーオーシャン市場を見つけるのに役立つように解説しています。
第6章:読者が異なる下流市場でブルーオーシャン市場を見つけるのを助けるために、各市場セグメントの市場規模および開発可能性をカバーする、アプリケーション別の様々な市場セグメントの分析を提供します。
第7章:主要企業のプロフィールを提供し、製品の生産/出力、価値、価格、粗利益率、製品紹介、最近の開発など、市場の主要企業の基本状況を詳細に紹介する。
第8章:産業の上流と下流を含む産業チェーンの分析。
第9章:市場力学、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析などを紹介する。
第10章:本レポートの要点と結論。

ページTOPに戻る


目次

1 Bovine Heparin Sodium Market Overview 1
1.1 Product Definition 1
1.2 Bovine Heparin Sodium by Application 1
1.2.1 Global Bovine Heparin Sodium Market Value Growth Rate Analysis by Application: 2023 VS 2029 1
1.2.2 Treatment of Venous Thromboembolism 3
1.2.3 Cardioversion of Atrial Fibrillation/Flutter 3
1.2.4 Complications of Pregnancy 3
1.3 Global Market Growth Prospects 4
1.3.1 Global Bovine Heparin Sodium Production Value Estimates and Forecasts (2018-2029) 4
1.3.2 Global Bovine Heparin Sodium Production Capacity Estimates and Forecasts (2018-2029) 6
1.3.3 Global Bovine Heparin Sodium Production Estimates and Forecasts (2018-2029) 6
1.3.4 Global Bovine Heparin Sodium Market Average Price Estimates and Forecasts (2018-2029) 8
1.4 Assumptions and Limitations 8
2 Market Competition by Manufacturers 11
2.1 Global Bovine Heparin Sodium Production Market Share by Manufacturers (2018-2023) 11
2.2 Global Bovine Heparin Sodium Production Value Market Share by Manufacturers (2018-2023) 13
2.3 Global Bovine Heparin Sodium Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 15
2.4 Global Bovine Heparin Sodium Average Price by Manufacturers (2018-2023) 16
2.5 Global Key Manufacturers of Bovine Heparin Sodium, Manufacturing Base Distribution and Headquarters 17
2.6 Bovine Heparin Sodium Market Competitive Situation and Trends 17
2.6.1 Bovine Heparin Sodium Market Concentration Rate 17
2.6.2 Global 5 Largest Bovine Heparin Sodium Players Market Share by Revenue 18
2.7 Mergers & Acquisitions, Expansion 18
3 Bovine Heparin Sodium Production by Region 19
3.1 Global Bovine Heparin Sodium Production Value Estimates and Forecasts by Region: 2018 VS 2023 VS 2029 19
3.2 Global Bovine Heparin Sodium Production Value by Region (2018-2029) 20
3.2.1 Global Bovine Heparin Sodium Production Value Market Share by Region (2018-2023) 20
3.2.2 Global Forecasted Production Value of Bovine Heparin Sodium by Region (2024-2029) 21
3.3 Global Bovine Heparin Sodium Production Estimates and Forecasts by Region: 2018 VS 2023 VS 2029 22
3.4 Global Bovine Heparin Sodium Production by Region (2018-2029) 22
3.4.1 Global Bovine Heparin Sodium Production Market Share by Region (2018-2023) 22
3.4.2 Global Forecasted Production of Bovine Heparin Sodium by Region (2024-2029) 23
3.5 Global Bovine Heparin Sodium Market Price Analysis by Region (2018-2023) 23
3.6 Global Bovine Heparin Sodium Production and Value, Year-over-Year Growth 24
3.6.1 South America Bovine Heparin Sodium Production Value Estimates and Forecasts (2018-2029) 24
3.6.2 India Bovine Heparin Sodium Production Value Estimates and Forecasts (2018-2029) 24
3.6.3 China Bovine Heparin Sodium Production Value Estimates and Forecasts (2018-2029) 25
4 Bovine Heparin Sodium Consumption by Region 27
4.1 Global Bovine Heparin Sodium Consumption Estimates and Forecasts by Region: 2018 VS 2023 VS 2029 27
4.2 Global Bovine Heparin Sodium Consumption by Region (2018-2029) 28
4.2.1 Global Bovine Heparin Sodium Consumption by Region (2018-2029) 28
4.2.2 Global Bovine Heparin Sodium Forecasted Consumption by Region (2024-2029) 29
4.3 North America 30
4.3.1 North America Bovine Heparin Sodium Consumption Growth Rate by Country: 2018 VS 2023 VS 2029 30
4.3.2 North America Bovine Heparin Sodium Consumption by Country (2018-2029) 31
4.3.3 U.S. 32
4.3.4 Canada 33
4.3.5 Mexico 34
4.4 Europe 35
4.4.1 Europe Bovine Heparin Sodium Consumption Growth Rate by Country: 2018 VS 2023 VS 2029 35
4.4.2 Europe Bovine Heparin Sodium Consumption by Country (2018-2029) 36
4.4.3 Germany 38
4.4.4 France 39
4.4.5 U.K. 40
4.4.6 Italy 41
4.4.7 Spain 42
4.5 Asia Pacific 43
4.5.1 Asia Pacific Bovine Heparin Sodium Consumption Growth Rate by Country: 2018 VS 2023 VS 2029 43
4.5.2 Asia Pacific Bovine Heparin Sodium Consumption by Region (2018-2029) 44
4.5.3 China 46
4.5.4 Japan 47
4.5.5 South Korea 48
4.5.6 Southeast Asia 49
4.5.7 India 50
4.5.8 Australia 51
4.6 South America 52
4.6.1 South America Bovine Heparin Sodium Consumption Growth Rate by Country: 2018 VS 2023 VS 2029 52
4.6.2 South America Bovine Heparin Sodium Consumption by Country (2018-2029) 53
4.6.3 Brazil 55
4.6.4 Argentina 56
4.7 Middle East & Africa 57
4.7.1 South America, Middle East & Africa Bovine Heparin Sodium Consumption Growth Rate by Country: 2018 VS 2023 VS 2029 57
4.7.2 Middle East & Africa Bovine Heparin Sodium Consumption by Country (2018-2029) 58
4.7.3 Middle East 59
4.7.4 Africa 60
5 Segment by Application 61
5.1 Global Bovine Heparin Sodium Production by Application (2018-2029) 61
5.1.1 Global Bovine Heparin Sodium Production by Application (2018-2023) 61
5.1.2 Global Bovine Heparin Sodium Production by Application (2024-2029) 61
5.1.3 Global Bovine Heparin Sodium Production Market Share by Application (2018-2029) 61
5.2 Global Bovine Heparin Sodium Production Value by Application (2018-2029) 63
5.2.1 Global Bovine Heparin Sodium Production Value by Application (2018-2023) 63
5.2.2 Global Bovine Heparin Sodium Production Value by Application (2024-2029) 63
5.2.3 Global Bovine Heparin Sodium Production Value Market Share by Application (2018-2029) 64
5.3 Global Bovine Heparin Sodium Price by Application (2018-2029) 65
6 Key Companies Profiled 67
6.1 Kin Master Produtos Químicos Ltda 67
6.1.1 Kin Master Produtos Químicos Ltda Bovine Heparin Sodium Company Information 67
6.1.2 Kin Master Produtos Químicos Ltda Bovine Heparin Sodium Product Portfolio 68
6.1.3 Kin Master Produtos Químicos Ltda Bovine Heparin Sodium Production, Value, Price and Gross Margin (2018-2023) 68
6.1.4 Kin Master Produtos Químicos Ltda Main Business and Markets Served 68
6.2 Syntex 69
6.2.1 Syntex Bovine Heparin Sodium Company Information 69
6.2.2 Syntex Bovine Heparin Sodium Product Portfolio 70
6.2.3 Syntex Bovine Heparin Sodium Production, Value, Price and Gross Margin (2018-2023) 70
6.2.4 Syntex Main Business and Markets Served 71
6.3 Bacto Chem 71
6.3.1 Bacto Chem Bovine Heparin Sodium Company Information 71
6.3.2 Bacto Chem Bovine Heparin Sodium Product Portfolio 72
6.3.3 Bacto Chem Bovine Heparin Sodium Production, Value, Price and Gross Margin (2018-2023) 72
6.3.4 Bacto Chem Main Business and Markets Served 73
6.4 Wegmed - Caminhos Medicinais Ltda 73
6.4.1 Wegmed - Caminhos Medicinais Ltda Bovine Heparin Sodium Company Information 73
6.4.2 Wegmed - Caminhos Medicinais Ltda Bovine Heparin Sodium Product Portfolio 74
6.4.3 Wegmed - Caminhos Medicinais Ltda Bovine Heparin Sodium Production, Value, Price and Gross Margin (2018-2023) 74
6.4.4 Wegmed - Caminhos Medicinais Ltda Main Business and Markets Served 75
6.5 Alliance Brasil 75
6.5.1 Alliance Brasil Bovine Heparin Sodium Company Information 75
6.5.2 Alliance Brasil Bovine Heparin Sodium Product Portfolio 76
6.5.3 Alliance Brasil Bovine Heparin Sodium Production, Value, Price and Gross Margin (2018-2023) 76
6.5.4 Alliance Brasil Main Business and Markets Served 76
6.6 Ralington Pharma 77
6.6.1 Ralington Pharma Bovine Heparin Sodium Company Information 77
6.6.2 Ralington Pharma Bovine Heparin Sodium Product Portfolio 77
6.6.3 Ralington Pharma Bovine Heparin Sodium Production, Value, Price and Gross Margin (2018-2023) 78
6.6.4 Ralington Pharma Main Business and Markets Served 78
6.7 Hebei Changshan Biochemical Pharmaceutical 79
6.7.1 Hebei Changshan Biochemical Pharmaceutical Bovine Heparin Sodium Company Information 79
6.7.2 Hebei Changshan Biochemical Pharmaceutical Bovine Heparin Sodium Product Portfolio 80
6.7.3 Hebei Changshan Biochemical Pharmaceutical Bovine Heparin Sodium Production, Value, Price and Gross Margin (2018-2023) 80
6.7.4 Hebei Changshan Biochemical Pharmaceutical Main Business and Markets Served 81
6.8 Suzhou Ronnsi Pharma 81
6.8.1 Suzhou Ronnsi Pharma Bovine Heparin Sodium Company Information 81
6.8.2 Suzhou Ronnsi Pharma Bovine Heparin Sodium Product Portfolio 82
6.8.3 Suzhou Ronnsi Pharma Bovine Heparin Sodium Production, Value, Price and Gross Margin (2018-2023) 83
6.8.4 Suzhou Ronnsi Pharma Main Business and Markets Served 83
7 Industry Chain and Sales Channels Analysis 85
7.1 Bovine Heparin Sodium Industry Chain Analysis 85
7.2 Bovine Heparin Sodium Key Raw Materials 85
7.2.1 Key Raw Materials 85
7.2.2 Raw Materials Key Suppliers 86
7.3 Bovine Heparin Sodium Production Mode & Process 86
7.4 Bovine Heparin Sodium Sales and Marketing 87
7.4.1 Bovine Heparin Sodium Sales Channels 87
7.4.2 Bovine Heparin Sodium Distributors 87
7.5 Bovine Heparin Sodium Customers 88
8 Bovine Heparin Sodium Market Dynamics 90
8.1 Bovine Heparin Sodium Industry Trends 90
8.2 Bovine Heparin Sodium Market Drivers 91
8.3 Bovine Heparin Sodium Market Challenges 92
8.4 Bovine Heparin Sodium Market Restraints 92
9 Research Findings and Conclusion 93
10 Methodology and Data Source 94
10.1 Methodology/Research Approach 94
10.1.1 Research Programs/Design 94
10.1.2 Market Size Estimation 95
10.1.3 Market Breakdown and Data Triangulation 96
10.2 Data Source 97
10.2.1 Secondary Sources 97
10.2.2 Primary Sources 98
10.3 Author List 99
10.4 Disclaimer 101


 

ページTOPに戻る


 

Summary

The global Bovine Heparin Sodium market was valued at US$ 40.20 million in 2022 and is anticipated to reach US$ 57.40 million by 2029, witnessing a CAGR of 5.80% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The major global manufacturers of Bovine Heparin Sodium include Kin Master Produtos Químicos Ltda, Syntex, Bacto Chem, Wegmed - Caminhos Medicinais Ltda, and etc. In 2022, the world's top three vendors accounted for approximately 70.89% of the revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Bovine Heparin Sodium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bovine Heparin Sodium.

The Bovine Heparin Sodium market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Bovine Heparin Sodium market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bovine Heparin Sodium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company
Kin Master Produtos Químicos Ltda
Syntex
Bacto Chem
Wegmed - Caminhos Medicinais Ltda
Alliance Brasil
Ralington Pharma
Hebei Changshan Biochemical Pharmaceutical
Suzhou Ronnsi Pharma

Segment by Application
Treatment of Venous Thromboembolism
Cardioversion of Atrial Fibrillation/Flutter
Complications of Pregnancy
Others

Production by Region
South America
India
China

Consumption by Region
North America
U.S.
Canada
Mexico

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe

South America
Argentina
Rest of South America

Middle East and Africa
Middle East
Africa

Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bovine Heparin Sodium manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Bovine Heparin Sodium by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Bovine Heparin Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.



ページTOPに戻る


Table of Contents

1 Bovine Heparin Sodium Market Overview 1
1.1 Product Definition 1
1.2 Bovine Heparin Sodium by Application 1
1.2.1 Global Bovine Heparin Sodium Market Value Growth Rate Analysis by Application: 2023 VS 2029 1
1.2.2 Treatment of Venous Thromboembolism 3
1.2.3 Cardioversion of Atrial Fibrillation/Flutter 3
1.2.4 Complications of Pregnancy 3
1.3 Global Market Growth Prospects 4
1.3.1 Global Bovine Heparin Sodium Production Value Estimates and Forecasts (2018-2029) 4
1.3.2 Global Bovine Heparin Sodium Production Capacity Estimates and Forecasts (2018-2029) 6
1.3.3 Global Bovine Heparin Sodium Production Estimates and Forecasts (2018-2029) 6
1.3.4 Global Bovine Heparin Sodium Market Average Price Estimates and Forecasts (2018-2029) 8
1.4 Assumptions and Limitations 8
2 Market Competition by Manufacturers 11
2.1 Global Bovine Heparin Sodium Production Market Share by Manufacturers (2018-2023) 11
2.2 Global Bovine Heparin Sodium Production Value Market Share by Manufacturers (2018-2023) 13
2.3 Global Bovine Heparin Sodium Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 15
2.4 Global Bovine Heparin Sodium Average Price by Manufacturers (2018-2023) 16
2.5 Global Key Manufacturers of Bovine Heparin Sodium, Manufacturing Base Distribution and Headquarters 17
2.6 Bovine Heparin Sodium Market Competitive Situation and Trends 17
2.6.1 Bovine Heparin Sodium Market Concentration Rate 17
2.6.2 Global 5 Largest Bovine Heparin Sodium Players Market Share by Revenue 18
2.7 Mergers & Acquisitions, Expansion 18
3 Bovine Heparin Sodium Production by Region 19
3.1 Global Bovine Heparin Sodium Production Value Estimates and Forecasts by Region: 2018 VS 2023 VS 2029 19
3.2 Global Bovine Heparin Sodium Production Value by Region (2018-2029) 20
3.2.1 Global Bovine Heparin Sodium Production Value Market Share by Region (2018-2023) 20
3.2.2 Global Forecasted Production Value of Bovine Heparin Sodium by Region (2024-2029) 21
3.3 Global Bovine Heparin Sodium Production Estimates and Forecasts by Region: 2018 VS 2023 VS 2029 22
3.4 Global Bovine Heparin Sodium Production by Region (2018-2029) 22
3.4.1 Global Bovine Heparin Sodium Production Market Share by Region (2018-2023) 22
3.4.2 Global Forecasted Production of Bovine Heparin Sodium by Region (2024-2029) 23
3.5 Global Bovine Heparin Sodium Market Price Analysis by Region (2018-2023) 23
3.6 Global Bovine Heparin Sodium Production and Value, Year-over-Year Growth 24
3.6.1 South America Bovine Heparin Sodium Production Value Estimates and Forecasts (2018-2029) 24
3.6.2 India Bovine Heparin Sodium Production Value Estimates and Forecasts (2018-2029) 24
3.6.3 China Bovine Heparin Sodium Production Value Estimates and Forecasts (2018-2029) 25
4 Bovine Heparin Sodium Consumption by Region 27
4.1 Global Bovine Heparin Sodium Consumption Estimates and Forecasts by Region: 2018 VS 2023 VS 2029 27
4.2 Global Bovine Heparin Sodium Consumption by Region (2018-2029) 28
4.2.1 Global Bovine Heparin Sodium Consumption by Region (2018-2029) 28
4.2.2 Global Bovine Heparin Sodium Forecasted Consumption by Region (2024-2029) 29
4.3 North America 30
4.3.1 North America Bovine Heparin Sodium Consumption Growth Rate by Country: 2018 VS 2023 VS 2029 30
4.3.2 North America Bovine Heparin Sodium Consumption by Country (2018-2029) 31
4.3.3 U.S. 32
4.3.4 Canada 33
4.3.5 Mexico 34
4.4 Europe 35
4.4.1 Europe Bovine Heparin Sodium Consumption Growth Rate by Country: 2018 VS 2023 VS 2029 35
4.4.2 Europe Bovine Heparin Sodium Consumption by Country (2018-2029) 36
4.4.3 Germany 38
4.4.4 France 39
4.4.5 U.K. 40
4.4.6 Italy 41
4.4.7 Spain 42
4.5 Asia Pacific 43
4.5.1 Asia Pacific Bovine Heparin Sodium Consumption Growth Rate by Country: 2018 VS 2023 VS 2029 43
4.5.2 Asia Pacific Bovine Heparin Sodium Consumption by Region (2018-2029) 44
4.5.3 China 46
4.5.4 Japan 47
4.5.5 South Korea 48
4.5.6 Southeast Asia 49
4.5.7 India 50
4.5.8 Australia 51
4.6 South America 52
4.6.1 South America Bovine Heparin Sodium Consumption Growth Rate by Country: 2018 VS 2023 VS 2029 52
4.6.2 South America Bovine Heparin Sodium Consumption by Country (2018-2029) 53
4.6.3 Brazil 55
4.6.4 Argentina 56
4.7 Middle East & Africa 57
4.7.1 South America, Middle East & Africa Bovine Heparin Sodium Consumption Growth Rate by Country: 2018 VS 2023 VS 2029 57
4.7.2 Middle East & Africa Bovine Heparin Sodium Consumption by Country (2018-2029) 58
4.7.3 Middle East 59
4.7.4 Africa 60
5 Segment by Application 61
5.1 Global Bovine Heparin Sodium Production by Application (2018-2029) 61
5.1.1 Global Bovine Heparin Sodium Production by Application (2018-2023) 61
5.1.2 Global Bovine Heparin Sodium Production by Application (2024-2029) 61
5.1.3 Global Bovine Heparin Sodium Production Market Share by Application (2018-2029) 61
5.2 Global Bovine Heparin Sodium Production Value by Application (2018-2029) 63
5.2.1 Global Bovine Heparin Sodium Production Value by Application (2018-2023) 63
5.2.2 Global Bovine Heparin Sodium Production Value by Application (2024-2029) 63
5.2.3 Global Bovine Heparin Sodium Production Value Market Share by Application (2018-2029) 64
5.3 Global Bovine Heparin Sodium Price by Application (2018-2029) 65
6 Key Companies Profiled 67
6.1 Kin Master Produtos Químicos Ltda 67
6.1.1 Kin Master Produtos Químicos Ltda Bovine Heparin Sodium Company Information 67
6.1.2 Kin Master Produtos Químicos Ltda Bovine Heparin Sodium Product Portfolio 68
6.1.3 Kin Master Produtos Químicos Ltda Bovine Heparin Sodium Production, Value, Price and Gross Margin (2018-2023) 68
6.1.4 Kin Master Produtos Químicos Ltda Main Business and Markets Served 68
6.2 Syntex 69
6.2.1 Syntex Bovine Heparin Sodium Company Information 69
6.2.2 Syntex Bovine Heparin Sodium Product Portfolio 70
6.2.3 Syntex Bovine Heparin Sodium Production, Value, Price and Gross Margin (2018-2023) 70
6.2.4 Syntex Main Business and Markets Served 71
6.3 Bacto Chem 71
6.3.1 Bacto Chem Bovine Heparin Sodium Company Information 71
6.3.2 Bacto Chem Bovine Heparin Sodium Product Portfolio 72
6.3.3 Bacto Chem Bovine Heparin Sodium Production, Value, Price and Gross Margin (2018-2023) 72
6.3.4 Bacto Chem Main Business and Markets Served 73
6.4 Wegmed - Caminhos Medicinais Ltda 73
6.4.1 Wegmed - Caminhos Medicinais Ltda Bovine Heparin Sodium Company Information 73
6.4.2 Wegmed - Caminhos Medicinais Ltda Bovine Heparin Sodium Product Portfolio 74
6.4.3 Wegmed - Caminhos Medicinais Ltda Bovine Heparin Sodium Production, Value, Price and Gross Margin (2018-2023) 74
6.4.4 Wegmed - Caminhos Medicinais Ltda Main Business and Markets Served 75
6.5 Alliance Brasil 75
6.5.1 Alliance Brasil Bovine Heparin Sodium Company Information 75
6.5.2 Alliance Brasil Bovine Heparin Sodium Product Portfolio 76
6.5.3 Alliance Brasil Bovine Heparin Sodium Production, Value, Price and Gross Margin (2018-2023) 76
6.5.4 Alliance Brasil Main Business and Markets Served 76
6.6 Ralington Pharma 77
6.6.1 Ralington Pharma Bovine Heparin Sodium Company Information 77
6.6.2 Ralington Pharma Bovine Heparin Sodium Product Portfolio 77
6.6.3 Ralington Pharma Bovine Heparin Sodium Production, Value, Price and Gross Margin (2018-2023) 78
6.6.4 Ralington Pharma Main Business and Markets Served 78
6.7 Hebei Changshan Biochemical Pharmaceutical 79
6.7.1 Hebei Changshan Biochemical Pharmaceutical Bovine Heparin Sodium Company Information 79
6.7.2 Hebei Changshan Biochemical Pharmaceutical Bovine Heparin Sodium Product Portfolio 80
6.7.3 Hebei Changshan Biochemical Pharmaceutical Bovine Heparin Sodium Production, Value, Price and Gross Margin (2018-2023) 80
6.7.4 Hebei Changshan Biochemical Pharmaceutical Main Business and Markets Served 81
6.8 Suzhou Ronnsi Pharma 81
6.8.1 Suzhou Ronnsi Pharma Bovine Heparin Sodium Company Information 81
6.8.2 Suzhou Ronnsi Pharma Bovine Heparin Sodium Product Portfolio 82
6.8.3 Suzhou Ronnsi Pharma Bovine Heparin Sodium Production, Value, Price and Gross Margin (2018-2023) 83
6.8.4 Suzhou Ronnsi Pharma Main Business and Markets Served 83
7 Industry Chain and Sales Channels Analysis 85
7.1 Bovine Heparin Sodium Industry Chain Analysis 85
7.2 Bovine Heparin Sodium Key Raw Materials 85
7.2.1 Key Raw Materials 85
7.2.2 Raw Materials Key Suppliers 86
7.3 Bovine Heparin Sodium Production Mode & Process 86
7.4 Bovine Heparin Sodium Sales and Marketing 87
7.4.1 Bovine Heparin Sodium Sales Channels 87
7.4.2 Bovine Heparin Sodium Distributors 87
7.5 Bovine Heparin Sodium Customers 88
8 Bovine Heparin Sodium Market Dynamics 90
8.1 Bovine Heparin Sodium Industry Trends 90
8.2 Bovine Heparin Sodium Market Drivers 91
8.3 Bovine Heparin Sodium Market Challenges 92
8.4 Bovine Heparin Sodium Market Restraints 92
9 Research Findings and Conclusion 93
10 Methodology and Data Source 94
10.1 Methodology/Research Approach 94
10.1.1 Research Programs/Design 94
10.1.2 Market Size Estimation 95
10.1.3 Market Breakdown and Data Triangulation 96
10.2 Data Source 97
10.2.1 Secondary Sources 97
10.2.2 Primary Sources 98
10.3 Author List 99
10.4 Disclaimer 101


 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/09/19 10:28

144.64 円

160.77 円

193.27 円

ページTOPに戻る